← Back to search

INSULET CORPORATION

PODD · NASDAQ

Surgical and Medical Instrument Manufacturing

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

ESG Scores

Overall ESG
8.2
Environmental
8.7
Social
6.4
Governance
5.5

Public ESG Grades

Overall: B (Medium)
E: BS: BG: B

Gender Diversity

Female Directors0.5556%
Female Executives0.1932367149758454%
Women in Workforce0.47%
CEO GenderMale